Market statusEarly Stage Concept

Products 31 to 40 of 69

Biotech components: Gene Editing + Plant
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:47 (2 years ago)
Date last modified: 2019/09/12 14:47 (2 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture + Novelty
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Plant
Production process: N/A
Source: N/A
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Gen 3 technical and medical fiber by Kraig Biocraft Laboratories
Biotech components: Animal
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/08/30 11:49 (3 years ago)
Known funding amount: 1,200,000 USD
Funding types: Shareholder Investment + Government
Industry: Medical + Industrial
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Fiber
Production process: Closed Production
Source: Web search
Trading symbol: KBLB (OTCQB)
Value chain stage: Input
Genetic Security System by Wyss Institute + Harvard University
Biotech components: Bacteria
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/08/30 11:49 (3 years ago)
Known funding amount: 3,700,000 USD
Funding types: Government
Industry: Security
Market status: Early Stage Concept
Organization type(s): Research Institution
Product categories: Forensic Tagging
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Input
Gluten Reduced Wheat by Catalyxt
Biotech components: Plant
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/08/30 11:49 (3 years ago)
Known funding amount: 608,825,000 USD
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Plant
Production process: Open Release
Source: Web search
Trading symbol: CLXT (NASDAQ)
Value chain stage: Finished Product
GM Yeast to make Cannabis by University of California, Berkeley + Demetrix Inc.
Biotech components: Yeast
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:18 (2 years ago)
Date last modified: 2019/09/12 15:18 (2 years ago)
Known funding amount: 11,000,000 USD
Funding types: Venture Capital
Industry: Medical
Market status: Early Stage Concept
Organization type(s): Private Company + University
Product categories: Medicine
Production process: N/A
Source: Scientist Magazine
Trading symbol: N/A
Value chain stage: Input
GMO Low-Fat Pigs by Institute of Zoology at the Chinese Academy of Sciences
Biotech components: Animal
Business models: B2B
Country of production: China
Country of distribution: China
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/10/08 14:49 (3 years ago)
Known funding amount: N/A
Funding types: Government
Industry: Food & Agriculture
Market status: Early Stage Concept
Organization type(s): Research Institution + University
Product categories: Animal
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Improved Rubisco by ARC Center of Excellence for Translational Photosynthesis at the Australian National University
Biotech components: Bacteria
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:38 (4 months ago)
Date last modified: 2020/12/18 14:38 (4 months ago)
Known funding amount: N/A
Funding types: University
Industry: Food & Agriculture
Market status: Early Stage Concept
Organization type(s): University
Product categories: Plant
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Input
Insulin-producing bacteria by Venter Institute
Biotech components: Bacteria
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/10/01 09:50 (3 years ago)
Known funding amount: 50,000 USD
Funding types: Foundation
Industry: Health
Market status: Early Stage Concept
Organization type(s): Research Institution
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product
Mandelic Acid by MONAD Nanotech + Birla College
Biotech components: Plant
Business models: B2B
Country of production: India
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (3 years ago)
Date last modified: 2018/08/30 11:49 (3 years ago)
Known funding amount: N/A
Funding types: University + Government
Industry: Health
Market status: Early Stage Concept
Organization type(s): University
Product categories: Personal Care (Topical) + Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input
Mast-MO (antibiotic wasp venom) by University of Pennsylvania’s Perelman School of Medicine
Biotech components: Animal + Bacteria + Molecule
Business models: B2B + B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:40 (4 months ago)
Date last modified: 2020/12/18 14:40 (4 months ago)
Known funding amount: N/A
Funding types: University
Industry: Medical
Market status: Early Stage Concept
Organization type(s): University
Product categories: Medical Treatment
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Input